Page last updated: 2024-12-07

2-(2,3-dicarboxycyclopropyl)glycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-(2,3-dicarboxycyclopropyl)glycine, often shortened to **DCCG**, is a non-proteinogenic amino acid. This means it's not found naturally in proteins, but it has interesting biological properties that make it relevant for research.

**Here's a breakdown of DCCG and its significance:**

* **Structure:** DCCG has a cyclopropane ring with two carboxyl groups (COOH) attached, and a glycine molecule attached to the ring. This unique structure makes it different from common amino acids.
* **Function:** DCCG is a potent and selective inhibitor of the enzyme **glycine transporter 1 (GlyT1)**. GlyT1 is a protein found in the nervous system that is responsible for removing glycine from the synaptic cleft (the space between neurons).
* **Importance in Research:**
* **Neurological Disorders:** By blocking GlyT1, DCCG increases the levels of glycine in the synapse. Glycine plays a vital role in neurotransmission, particularly in the spinal cord and brain stem. This makes DCCG relevant for studying:
* **Spinal cord injury:** Glycine is involved in pain pathways, and increasing its levels with DCCG might be a therapeutic target.
* **Parkinson's disease:** Some evidence suggests that glycine levels are altered in this disorder, and DCCG might help understand the role of glycine in Parkinson's pathogenesis.
* **Drug Development:** DCCG serves as a valuable tool for developing new drugs that target GlyT1. Its selectivity for this transporter makes it a good starting point for designing more potent and specific inhibitors.
* **Basic Neuroscience Research:** DCCG is also useful for researchers investigating the role of glycine in various neurological processes and its interaction with other neurotransmitters.

**It's important to note that:**

* While DCCG shows promise in research, it's still under investigation and is not currently used clinically.
* Further studies are needed to fully understand the effects of DCCG and its potential therapeutic applications.

Overall, 2-(2,3-dicarboxycyclopropyl)glycine is an important research tool because of its ability to selectively block GlyT1, which opens up possibilities for investigating and potentially treating a range of neurological conditions.

2-(2,3-dicarboxycyclopropyl)glycine, also known as **DCPG**, is a non-proteinogenic amino acid. It's not a natural amino acid found in proteins, but it has significant potential for research due to its unique structure and biological activity.

**Structure:**

* DCPG contains a cyclopropane ring with two carboxyl groups attached to it.
* This unique structure provides it with a rigid and strained conformation, which can influence its interactions with biological molecules.
* The presence of two carboxyl groups adds to its potential for interaction with enzymes and other proteins.

**Importance for Research:**

**1. Potential Anti-Cancer Agent:**

* Studies have shown that DCPG inhibits the growth of certain cancer cells, particularly leukemia and lymphoma cells.
* This suggests that DCPG could be a potential therapeutic agent for these diseases.
* Its mechanism of action is thought to involve disruption of cellular processes like cell cycle regulation and DNA synthesis.

**2. Enzyme Inhibition:**

* DCPG has been found to inhibit the activity of certain enzymes, including some involved in the metabolism of amino acids and neurotransmitters.
* This suggests that it could be a valuable tool for studying enzyme function and for developing new drugs that target specific enzymes.

**3. Probing Protein Structure and Function:**

* DCPG's unusual structure and potential for interaction with biological molecules make it a valuable probe for studying protein structure and function.
* Researchers can use it to understand how proteins interact with small molecules and to develop new tools for protein engineering.

**4. Potential in Neurological Research:**

* DCPG has been shown to affect the activity of certain neurotransmitters, suggesting potential applications in neurological research.
* It might be used to investigate the role of specific neurotransmitters in different neurological disorders.

**Limitations and Further Research:**

While DCPG shows promising potential in various areas, further research is necessary to fully understand its properties and potential therapeutic applications.

* **Toxicity and side effects:** More research is needed to assess the safety and potential side effects of DCPG in humans.
* **Dosage and delivery:** Determining the optimal dosage and delivery method for DCPG is crucial for its future clinical application.
* **Specificity:** Investigating the specific mechanisms of action and target proteins of DCPG is essential for its development as a targeted therapeutic agent.

Overall, 2-(2,3-dicarboxycyclopropyl)glycine holds significant promise for research in cancer, enzyme inhibition, protein structure and function, and neurology. Further research is needed to fully understand its potential and translate its findings into clinical applications.

Cross-References

ID SourceID
PubMed CID5310979
CHEMBL ID284193
SCHEMBL ID658075
MeSH IDM0219368
PubMed CID115114
SCHEMBL ID665348
MeSH IDM0219368

Synonyms (26)

Synonym
(2s,2''r,3''r)-2-(2'',3'')-dicarboxycyclopropylglycine
(1r,2r)-3-((s)-amino-carboxy-methyl)-cyclopropane-1,2-dicarboxylic acid
(1r,2r)-3-[(s)-amino(carboxy)methyl]cyclopropane-1,2-dicarboxylic acid
3-(amino-carboxy-methyl)-cyclopropane-1,2-dicarboxylic acid
bdbm50034503
gtpl1377
dcg-iv
CHEMBL284193 ,
(1r,2r)-3-[(1s)-1-amino-2-hydroxy-2-oxoethyl]cyclopropane-1,2-dicarboxylic acid
2cg ,
SCHEMBL658075
dcgiv
1,2-cyclopropanedicarboxylicacid,3-[(s)-aminocarboxymethyl]-,(1r,2r)-
AKOS030230932
MATPZHBYOVDBLI-JJYYJPOSSA-N
CS-0021174
Q5204500
HY-101335
1,2-cyclopropanedicarboxylic acid, 3-[(s)-aminocarboxymethyl]-, (1r,2r)-
(1r,2r)-3-[(s)-amino(carboxy)methyl]cyclopropane-1,2-dicarboxylicacid
1,2-cyclopropanedicarboxylic acid, 3-(aminocarboxymethyl)-, (1r-(1alpha,2beta,3alpha(s*)))-
2-(2,3-dicarboxycyclopropyl)glycine
147782-19-2
SCHEMBL665348
DTXSID00933208
(1r)-3-[(s)-amino(carboxy)methyl]cyclopropane-1,2-dicarboxylic acid

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves showed that DCG-IV was weaker than NMDA but more potent than glutamate in eliciting agonist-gated currents."( Metabotropic glutamate receptor agonist DCG-IV as NMDA receptor agonist in immature rat hippocampal neurons.
Opitz, T; Pidoplichko, VI; Reymann, KG; Shinozaki, H; Wilsch, VW, 1994
)
0.29
" The glutamate- or NAAG-mediated blockage of calcium channels showed indistinguishable dose-response curves, with K1/2 = 388 and 350 nM for glutamate and NAAG, respectively."( Glutamate and N-acetylaspartylglutamate block HVA calcium currents in frog olfactory bulb interneurons via an mGluR2/3-like receptor.
Bischofberger, J; Schild, D, 1996
)
0.29
" A dose-response study demonstrated that doses of DCG-IV as low as 5 nmol was very toxic in terms GAD mRNA and apoptosis."( DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury.
Cano, J; Machado, A; Matarredona, ER; Santiago, M; Tomás-Camardiel, M; Venero, JL, 2002
)
0.31
" However, LY487379 markedly potentiated glutamate-stimulated [35S]GTPgammaS binding in a concentration-dependent manner at hmGluR2, shifting the glutamate dose-response curve leftward by 3-fold and increasing the maximum levels of [35S]GTPgammaS stimulation."( Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
Bain, G; Bristow, LJ; Chavez-Noriega, LE; Daggett, LP; Jachec, C; Morales, S; Pinkerton, AB; Rao, SP; Rowe, BA; Schaffhauser, H; Varney, MA; Vernier, JM; Yin, R, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (16)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Metabotropic glutamate receptor 1Rattus norvegicus (Norway rat)IC50 (µMol)389.00000.00020.58878.9900AID108514
Metabotropic glutamate receptor 1Rattus norvegicus (Norway rat)Ki77.00000.00790.31450.9000AID108493
Metabotropic glutamate receptor 2Homo sapiens (human)Ki0.11000.00270.71586.4000AID108837
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Metabotropic glutamate receptor 1Rattus norvegicus (Norway rat)EC50 (µMol)550.00000.20004.494610.0000AID108498; AID108502
Metabotropic glutamate receptor 2Rattus norvegicus (Norway rat)EC50 (µMol)0.24880.00061.42627.7000AID108845; AID108982; AID1289828; AID476360
Metabotropic glutamate receptor 3Rattus norvegicus (Norway rat)EC50 (µMol)0.19330.00211.89099.0000AID109170; AID109176; AID1289829
Metabotropic glutamate receptor 4Rattus norvegicus (Norway rat)EC50 (µMol)511.50000.00902.54409.4900AID109466; AID109472
Metabotropic glutamate receptor 5Rattus norvegicus (Norway rat)EC50 (µMol)389.00000.00151.653710.0000AID107066
Metabotropic glutamate receptor 6Rattus norvegicus (Norway rat)EC50 (µMol)40.00000.05502.40307.6000AID107247
Metabotropic glutamate receptor 7Rattus norvegicus (Norway rat)EC50 (µMol)40.00000.14600.82301.5000AID107267
Metabotropic glutamate receptor 8Rattus norvegicus (Norway rat)EC50 (µMol)32.00000.03101.18138.0000AID107408
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Metabotropic glutamate receptor 8Homo sapiens (human)Activity32.00000.40001.20002.0000AID107269
Metabotropic glutamate receptor 6Homo sapiens (human)Activity40.00000.40001.33333.0000AID107091
Metabotropic glutamate receptor 5Homo sapiens (human)Activity389.00004.00004.55005.1000AID109491
Metabotropic glutamate receptor 1Homo sapiens (human)Activity100.00001.00001.00001.0000AID108354
Metabotropic glutamate receptor 2Homo sapiens (human)Activity0.30000.00060.76864.0000AID108669
Metabotropic glutamate receptor 3Homo sapiens (human)Activity0.20000.00271.63819.0000AID109149
Metabotropic glutamate receptor 4Homo sapiens (human)Activity23.00004.00004.00004.0000AID109323
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (51)

Processvia Protein(s)Taxonomy
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 8Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 8Homo sapiens (human)
visual perceptionMetabotropic glutamate receptor 8Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 8Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 8Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 6Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 6Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 6Homo sapiens (human)
locomotory behaviorMetabotropic glutamate receptor 6Homo sapiens (human)
detection of visible lightMetabotropic glutamate receptor 6Homo sapiens (human)
detection of light stimulus involved in visual perceptionMetabotropic glutamate receptor 6Homo sapiens (human)
retina development in camera-type eyeMetabotropic glutamate receptor 6Homo sapiens (human)
positive regulation of calcium ion import across plasma membraneMetabotropic glutamate receptor 6Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 6Homo sapiens (human)
desensitization of G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of DNA-templated transcriptionMetabotropic glutamate receptor 5Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
phospholipase C-activating G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 5Homo sapiens (human)
learning or memoryMetabotropic glutamate receptor 5Homo sapiens (human)
learningMetabotropic glutamate receptor 5Homo sapiens (human)
locomotory behaviorMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of MAPK cascadeMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of long-term neuronal synaptic plasticityMetabotropic glutamate receptor 5Homo sapiens (human)
synapse organizationMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of calcium-mediated signalingMetabotropic glutamate receptor 5Homo sapiens (human)
cognitionMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 5Homo sapiens (human)
cellular response to amyloid-betaMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 5Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionMetabotropic glutamate receptor 5Homo sapiens (human)
G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 1Homo sapiens (human)
phospholipase C-activating G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 1Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 1Homo sapiens (human)
locomotory behaviorMetabotropic glutamate receptor 1Homo sapiens (human)
sensory perception of painMetabotropic glutamate receptor 1Homo sapiens (human)
positive regulation of MAPK cascadeMetabotropic glutamate receptor 1Homo sapiens (human)
regulation of sensory perception of painMetabotropic glutamate receptor 1Homo sapiens (human)
regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 1Homo sapiens (human)
cellular response to electrical stimulusMetabotropic glutamate receptor 1Homo sapiens (human)
L-glutamate import across plasma membraneMetabotropic glutamate receptor 1Homo sapiens (human)
regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 1Homo sapiens (human)
negative regulation of adenylate cyclase activityMetabotropic glutamate receptor 2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 2Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 2Homo sapiens (human)
gene expressionMetabotropic glutamate receptor 2Homo sapiens (human)
glutamate secretionMetabotropic glutamate receptor 2Homo sapiens (human)
regulation of glutamate secretionMetabotropic glutamate receptor 2Homo sapiens (human)
regulation of dopamine secretionMetabotropic glutamate receptor 2Homo sapiens (human)
behavioral response to nicotineMetabotropic glutamate receptor 2Homo sapiens (human)
response to cocaineMetabotropic glutamate receptor 2Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionMetabotropic glutamate receptor 2Homo sapiens (human)
long-term synaptic depressionMetabotropic glutamate receptor 2Homo sapiens (human)
intracellular glutamate homeostasisMetabotropic glutamate receptor 2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionMetabotropic glutamate receptor 2Homo sapiens (human)
regulation of response to drugMetabotropic glutamate receptor 2Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 2Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 2Homo sapiens (human)
behavioral fear responseMetabotropic glutamate receptor 7Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 7Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 7Homo sapiens (human)
sensory perception of soundMetabotropic glutamate receptor 7Homo sapiens (human)
negative regulation of glutamate secretionMetabotropic glutamate receptor 7Homo sapiens (human)
axon developmentMetabotropic glutamate receptor 7Homo sapiens (human)
glycosylationMetabotropic glutamate receptor 7Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 7Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 7Homo sapiens (human)
negative regulation of adenylate cyclase activityMetabotropic glutamate receptor 3Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 3Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 3Homo sapiens (human)
gene expressionMetabotropic glutamate receptor 3Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmissionMetabotropic glutamate receptor 3Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 3Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 3Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 4Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 4Homo sapiens (human)
neurotransmitter secretionMetabotropic glutamate receptor 4Homo sapiens (human)
positive regulation of MAPK cascadeMetabotropic glutamate receptor 4Homo sapiens (human)
regulation of neuron apoptotic processMetabotropic glutamate receptor 4Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 4Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (19)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityMetabotropic glutamate receptor 8Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 8Homo sapiens (human)
group III metabotropic glutamate receptor activityMetabotropic glutamate receptor 8Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 6Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 6Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 6Homo sapiens (human)
protein homodimerization activityMetabotropic glutamate receptor 6Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 6Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 5Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
protein tyrosine kinase activator activityMetabotropic glutamate receptor 5Homo sapiens (human)
A2A adenosine receptor bindingMetabotropic glutamate receptor 5Homo sapiens (human)
identical protein bindingMetabotropic glutamate receptor 5Homo sapiens (human)
protein tyrosine kinase bindingMetabotropic glutamate receptor 5Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 5Homo sapiens (human)
G protein-coupled receptor activity involved in regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 5Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 1Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 1Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 1Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 1Homo sapiens (human)
neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled receptor activity involved in regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 2Homo sapiens (human)
calcium channel regulator activityMetabotropic glutamate receptor 2Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 2Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 2Homo sapiens (human)
scaffold protein bindingMetabotropic glutamate receptor 2Homo sapiens (human)
group II metabotropic glutamate receptor activityMetabotropic glutamate receptor 2Homo sapiens (human)
group III metabotropic glutamate receptor activityMetabotropic glutamate receptor 7Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 7Homo sapiens (human)
adenylate cyclase inhibitor activityMetabotropic glutamate receptor 7Homo sapiens (human)
protein dimerization activityMetabotropic glutamate receptor 7Homo sapiens (human)
serine bindingMetabotropic glutamate receptor 7Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 3Homo sapiens (human)
calcium channel regulator activityMetabotropic glutamate receptor 3Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 3Homo sapiens (human)
scaffold protein bindingMetabotropic glutamate receptor 3Homo sapiens (human)
group II metabotropic glutamate receptor activityMetabotropic glutamate receptor 3Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 4Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 4Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (27)

Processvia Protein(s)Taxonomy
plasma membraneMetabotropic glutamate receptor 8Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 8Homo sapiens (human)
Golgi membraneMetabotropic glutamate receptor 6Homo sapiens (human)
endoplasmic reticulum membraneMetabotropic glutamate receptor 6Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 6Homo sapiens (human)
dendriteMetabotropic glutamate receptor 6Homo sapiens (human)
new growing cell tipMetabotropic glutamate receptor 6Homo sapiens (human)
synapseMetabotropic glutamate receptor 6Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 6Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneMetabotropic glutamate receptor 4Rattus norvegicus (Norway rat)
dendriteMetabotropic glutamate receptor 5Homo sapiens (human)
cytoplasmMetabotropic glutamate receptor 5Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 5Homo sapiens (human)
dendritic spineMetabotropic glutamate receptor 5Homo sapiens (human)
dendritic shaftMetabotropic glutamate receptor 5Homo sapiens (human)
astrocyte projectionMetabotropic glutamate receptor 5Homo sapiens (human)
Schaffer collateral - CA1 synapseMetabotropic glutamate receptor 5Homo sapiens (human)
glutamatergic synapseMetabotropic glutamate receptor 5Homo sapiens (human)
postsynaptic density membraneMetabotropic glutamate receptor 5Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 5Homo sapiens (human)
nucleusMetabotropic glutamate receptor 1Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 1Homo sapiens (human)
dendriteMetabotropic glutamate receptor 1Homo sapiens (human)
Schaffer collateral - CA1 synapseMetabotropic glutamate receptor 1Homo sapiens (human)
glutamatergic synapseMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled receptor dimeric complexMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled receptor homodimeric complexMetabotropic glutamate receptor 1Homo sapiens (human)
postsynaptic density membraneMetabotropic glutamate receptor 1Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 1Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 2Homo sapiens (human)
axonMetabotropic glutamate receptor 2Homo sapiens (human)
dendriteMetabotropic glutamate receptor 2Homo sapiens (human)
presynaptic membraneMetabotropic glutamate receptor 2Homo sapiens (human)
astrocyte projectionMetabotropic glutamate receptor 2Homo sapiens (human)
glutamatergic synapseMetabotropic glutamate receptor 2Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 2Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 7Homo sapiens (human)
cell cortexMetabotropic glutamate receptor 7Homo sapiens (human)
membraneMetabotropic glutamate receptor 7Homo sapiens (human)
axonMetabotropic glutamate receptor 7Homo sapiens (human)
dendriteMetabotropic glutamate receptor 7Homo sapiens (human)
asymmetric synapseMetabotropic glutamate receptor 7Homo sapiens (human)
dendritic shaftMetabotropic glutamate receptor 7Homo sapiens (human)
postsynaptic membraneMetabotropic glutamate receptor 7Homo sapiens (human)
presynaptic active zoneMetabotropic glutamate receptor 7Homo sapiens (human)
receptor complexMetabotropic glutamate receptor 7Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 7Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 3Homo sapiens (human)
postsynaptic densityMetabotropic glutamate receptor 3Homo sapiens (human)
axonMetabotropic glutamate receptor 3Homo sapiens (human)
presynaptic membraneMetabotropic glutamate receptor 3Homo sapiens (human)
dendritic spineMetabotropic glutamate receptor 3Homo sapiens (human)
postsynaptic membraneMetabotropic glutamate receptor 3Homo sapiens (human)
astrocyte projectionMetabotropic glutamate receptor 3Homo sapiens (human)
glutamatergic synapseMetabotropic glutamate receptor 3Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 3Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 4Homo sapiens (human)
cytoplasmic vesicleMetabotropic glutamate receptor 4Homo sapiens (human)
presynapseMetabotropic glutamate receptor 4Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (38)

Assay IDTitleYearJournalArticle
AID1346276Rat mGlu1 receptor (Metabotropic glutamate receptors)2000Journal of neurochemistry, Dec, Volume: 75, Issue:6
Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections.
AID1346287Rat mGlu2 receptor (Metabotropic glutamate receptors)2000Neuropharmacology, Jul-24, Volume: 39, Issue:10
Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectors.
AID1346255Rat mGlu6 receptor (Metabotropic glutamate receptors)1998Neuropharmacology, Aug, Volume: 37, Issue:8
Comparative effect of L-CCG-I, DCG-IV and gamma-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes.
AID1346287Rat mGlu2 receptor (Metabotropic glutamate receptors)1998British journal of pharmacology, Feb, Volume: 123, Issue:3
Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
AID1346254Rat mGlu5 receptor (Metabotropic glutamate receptors)2000Journal of neurochemistry, Dec, Volume: 75, Issue:6
Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections.
AID1346271Human mGlu2 receptor (Metabotropic glutamate receptors)1999Neuropharmacology, Oct, Volume: 38, Issue:10
[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells.
AID1346282Human mGlu8 receptor (Metabotropic glutamate receptors)1999Brain research. Molecular brain research, Apr-20, Volume: 67, Issue:2
Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8.
AID1346263Human mGlu7 receptor (Metabotropic glutamate receptors)2000Naunyn-Schmiedeberg's archives of pharmacology, Dec, Volume: 362, Issue:6
Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes.
AID107091Inhibition of c-AMP by human Metabotropic glutamate receptor 6 (mGluR6) expressed in non-neuronal cells2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
AID109176Metabotropic glutamate receptor 3 agonist activity against forskolin stimulated c-AMP formation in rat non neuronal cells2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
AID109491Phosphoinositide hydrolysis by human Metabotropic glutamate receptor 5 (mGluR5) expressed in non neuronal cells2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
AID109466Concentration for half maximal activation of metabotropic glutamate mGluR4a in rat1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
Metabotropic glutamate receptors: novel targets for drug development.
AID108669Inhibition of c-AMP by human Metabotropic glutamate receptor 2 (mGluR2) expressed in non-neuronal cells2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
AID107066Metabotropic glutamate receptor 5 agonist activity as basal [3H]- IP formation in rat2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
AID1289829Agonist activity at rat mGlu3 receptor by FRET based mGlu sensor assay2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
New 4-Functionalized Glutamate Analogues Are Selective Agonists at Metabotropic Glutamate Receptor Subtype 2 or Selective Agonists at Metabotropic Glutamate Receptor Group III.
AID231225Potency at metabotropic glutamate receptor 4, measured as the ratio of EC50 to IC502002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity.
AID108502Metabotropic glutamate receptor 1 agonist activity as basal [3H]- IP formation in rat2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
AID109472Metabotropic glutamate receptor 4 antagonist activity to influence forskolin stimulated c-AMP formation in rat non neuronal cells2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
AID476360Agonist activity at rat mGlu2 receptor expressed in HEK293 cells assessed as increase in intracellular calcium level after 1 hr by fluorescence microplate reader2010Journal of medicinal chemistry, Apr-08, Volume: 53, Issue:7
A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.
AID108498Concentration for half maximal activation of metabotropic glutamate mGluR1a in rat1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
Metabotropic glutamate receptors: novel targets for drug development.
AID107408Metabotropic glutamate receptor 8 antagonist activity to influence forskolin stimulated c-AMP formation in rat non neuronal cells2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
AID108845Concentration for half maximal activation of metabotropic glutamate mGluR2 in rat1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
Metabotropic glutamate receptors: novel targets for drug development.
AID231224Potency at metabotropic glutamate receptor 2, measured as the ratio of EC50 to IC502002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity.
AID108493Inhibition of binding to rat mGluR1a (metabotropic glutamate receptor) expressed in HEK-293 cells2002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity.
AID1289828Agonist activity at rat mGlu2 receptor by FRET based mGlu sensor assay2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
New 4-Functionalized Glutamate Analogues Are Selective Agonists at Metabotropic Glutamate Receptor Subtype 2 or Selective Agonists at Metabotropic Glutamate Receptor Group III.
AID109149Inhibition of c-AMP by human Metabotropic glutamate receptor 3 (mGluR3) expressed in non-neuronal cells2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
AID107267Metabotropic glutamate receptor 7 antagonist activity to influence forskolin stimulated c-AMP formation in rat non neuronal cells2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
AID107247Metabotropic glutamate receptor 6 antagonist activity to influence forskolin stimulated c-AMP formation in rat non neuronal cells2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
AID108354Phosphoinositide hydrolysis by human Metabotropic glutamate receptor 1 (mGluR1) expressed in non-neuronal cells2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
AID108982Metabotropic glutamate receptor 2 agonist activity against forskolin stimulated c-AMP formation in rat non neuronal cells2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
AID108837Binding affinity at Metabotropic glutamate receptor 22002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity.
AID108985Ratio between EC50 of compound and glutamate measured against Metabotropic glutamate receptor 21999Journal of medicinal chemistry, May-06, Volume: 42, Issue:9
Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.
AID109323Inhibition of c-AMP by human Metabotropic glutamate receptor 4 (mGluR4) expressed in non-neuronal cells2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
AID231223Potency at metabotropic glutamate receptor 1, measured as the ratio of EC50 to IC502002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Common and selective molecular determinants involved in metabotopic glutamate receptor agonist activity.
AID108514Inhibitory activity against Metabotropic glutamate receptor 1 in the rat LLC-PK1/HEK 293 cells.1999Journal of medicinal chemistry, May-06, Volume: 42, Issue:9
Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.
AID107258Inhibition of c-AMP by human Metabotropic glutamate receptor 7 mGluR7) expressed in non-neuronal cells2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
AID107269Inhibition of c-AMP by human Metabotropic glutamate receptor 8 (mGluR8) expressed in non-neuronal cells2002Journal of medicinal chemistry, Aug-15, Volume: 45, Issue:17
(2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-methylcyclopropyl) glycine is a potent and selective metabotropic group 2 receptor agonist with anxiolytic properties.
AID109170Concentration for half maximal activation of metabotropic glutamate mGluR3 in rat1995Journal of medicinal chemistry, Apr-28, Volume: 38, Issue:9
Metabotropic glutamate receptors: novel targets for drug development.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (175)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's60 (34.29)18.2507
2000's81 (46.29)29.6817
2010's33 (18.86)24.3611
2020's1 (0.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.23 (24.57)
Research Supply Index5.12 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Reviews1 (0.60%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
Other165 (99.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]